Showing results (11-20 of 103) with videos related to

Sort By:
Pageof 11
Seminars in Hematology|August 7, 2016
Treatment of advanced-stage Hodgkin lymphomaTheodoros P Vassilakopoulos, Peter W M Johnson
Drug Discovery Today|April 12, 2012
Stratified medicine for cancer therapyEmily C Shaw, Peter W M Johnson
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine|August 12, 2017
<sup>18</sup>F-FDG PET/CT in Lymphoma: Has Imaging-Directed Personalized Medicine Become a Reality?Sally F Barrington, Peter W M Johnson
Best Practice & Research. Clinical Haematology|December 7, 2002
Molecular remission and non-Hodgkin's lymphomaAngela J Darby, Peter W M Johnson
Hematology. American Society of Hematology. Education Program|December 17, 2008
Primary mediastinal B-cell lymphomaPeter W M Johnson, Andrew J Davies
The International Journal of Biochemistry & Cell Biology|October 12, 2004
Mcl-1Jorg Michels, Peter W M Johnson, Graham Packham
Trials|November 11, 2018
RIVA - a phase IIa study of rituximab and varlilumab in relapsed or refractory B-cell malignancies: study protocol for a randomized controlled trialSean H Lim, Kim M Linton, Graham P Collins, et al.
Cancer Treatment Reviews|November 21, 2023
Antibody based therapies in Hodgkin lymphomaVivek S Radhakrishnan, Jemma Longley, Peter W M Johnson
Scientific Reports|February 4, 2018
Augmentation of CD134 (OX40)-dependent NK anti-tumour activity is dependent on antibody cross-linkingAnna H Turaj, Kerry L Cox, Christine A Penfold, et al.
Clinical Science (London, England : 1979)|July 13, 2006
Therapeutic potential of immunostimulatory monoclonal antibodiesJuliet C Gray, Peter W M Johnson, Martin J Glennie
Pageof 11